Browsing: Disease Discoveries

The finding may be useful in shortening drug treatments for those with the disease.

Serdar Bulun, MD, authored an article in the New England Journal of Medicine that combines recent uterine fibroid research into a useful framework for scientists, clinicians, patients and the pharmaceutical industry.

Scientists are working to determine if a specific receptor inhibitor could be used to augment chemotherapy or prevent relapse in individuals with the disease.

While it’s long been known that oxytocin promotes feelings of love, social bonding, and wellbeing, only recently have scientists discovered it’s link to anxiety-producing bad memories.

In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine® scientists have successfully transplanted islets, the cells that produce insulin, from one species to another. And the islets survived without immunosuppressive drugs.

Published in the Journal of the American Medical Association, scientists determined that patients with coronary artery disease and regional myocardial wall thinning often have only limited scarring.

A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.

In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be able to search for effective treatments.

New Northwestern Medicine preclinical research has for the first time identified the molecular trigger of uterine fibroids.

Alzheimer’s drug may act like bad electrician, messing up wiring in brain and nervous system.